The AAPS Journal

, Volume 9, Issue 3, pp E361–E370 | Cite as

Characterization of the distribution, polymorphism, and stability of nimodipine in its solid dispersions in polyethylene glycol by micro-Raman spectroscopy and powder x-ray diffraction

  • Aristides Docoslis
  • Krista L. Huszarik
  • George Z. Papageorgiou
  • Dimitrios Bikiaris
  • Anagnostis Stergiou
  • Emmanouel Georgarakis
Article

Abstract

In the present study, a series of solid dispersions of the drug nimodipine using polyethylene glycol as carrier were prepared following the hot-melt method. Micro-Raman spectroscopy in conjunction with X-ray powder diffractometry was used for the characterization of the solid structure, including spatial distribution, physical state, and presence of polymorphs, as well as storage stability of nimodipine in its solid formulations. The effect of storage time on drug stability was investigated by examination of the samples 6 months and 18 months after preparation. Confocal micro-Raman mapping performed on the samples showed that the drug was not uniformly distributed on a microscopic level. The presence of crystals of nimodipine with sizes varying between one and several micrometers was detected, and the crystal size seemed to increase with overall drug content. In samples examined 6 months after preparation it was found that the crystals existed mainly as the racemic compound, whereas after 18 months of storage mainly crystal conglomerates were observed.

Keywords

Solid dispersion nimodipine Raman spectroscopy polymorphism 

References

  1. 1.
    Campbell Roberts SN, William AC, Grimsey IM, Booth SW. Quantitative analysis of mannitol polymorphs. FT-Raman spectroscopy. J Pharm Biomed Anal. 2002;28: 1135–1147.PubMedCrossRefGoogle Scholar
  2. 2.
    De Spiegeleer B, Seghers D, Wieme R, et al. Determination of the relative amounts of three crystal forms of a benzimidazole drug in complex finished formulations by FT-Raman spectroscopy. J Pharm Biomed Anal. 2005;39:275–280.PubMedCrossRefGoogle Scholar
  3. 3.
    Tían F, Zeitler JA, Strachan CJ, Savílle DJ, Gordon KC, Rades T. Characterizing the conversion kinetics of carbamazepine polymorphs to the dihydrate in aqueous suspension using Raman spectroscopy. J Pharm Biomed Anal. 2006;40:271–280.PubMedCrossRefGoogle Scholar
  4. 4.
    Yu L, Reutzel SM, Stephenson GA. Physical characterization of polymorphic drugs: an integrated characterization strategy. Pharm Sci Tech Today. 1998;1:118–127.CrossRefGoogle Scholar
  5. 5.
    Stephenson GA, Pfeiffer RR, Byrn SR. Solid-state investigation of the tautomerism of acetohexamide. Int J Pharm. 1997;146:93–99.CrossRefGoogle Scholar
  6. 6.
    Threlfall TL. Analysis of organic polymorphs: a review. Analyst. 1995;120:2435–2460.CrossRefGoogle Scholar
  7. 7.
    Huong PV. Drug analysis by Raman and micro-Raman spectroscopy. J Pharm Biomed Anal, 1986;4:811–823.PubMedCrossRefGoogle Scholar
  8. 8.
    Huong PV. New possibilities of Raman micro-spectroscopy. Vib Spectrosc. 1996;11:17–28.CrossRefGoogle Scholar
  9. 9.
    Fini G. Applications of Raman spectroscopy to pharmacy. J Raman Spectrosc. 2004;35:335–337.CrossRefGoogle Scholar
  10. 10.
    Sharonov S, Chourpa I, Morjani H, Nabiev I, Manfait M. Feofanov A. Confocal spectral imaging analysis in studies of the spatial distribution of antitumor drugs within living cancer cells. Anal Chim Acta. 1994;290:40–47.CrossRefGoogle Scholar
  11. 11.
    Grunenberg A, Keil B, Heck JO. Polymorphism in binary mixtures, as exemplified by nimodipine. Int J Pharm. 1995;118:11–21.CrossRefGoogle Scholar
  12. 12.
    Grunenberg A, Henck JO, Siesler HW. Theoretical derivation and practical application of energy/temperature diagrams as an instrument in preformulation studies of polymorphic drug substances. Int J Pharm. 1996;129:147–158.CrossRefGoogle Scholar
  13. 13.
    Cardoso TM, Rodrigues PO, Stulzer HK, Silva MAS, Matos JR. Physical-chemical characterization and polymorphism determination of two nimodipine samples deriving from distinct laboratories. Drug Dev Ind Pharm. 2005;31:631–637.PubMedCrossRefGoogle Scholar
  14. 14.
    Wang SD, Herbette LG, Rhodes DG. Structure of the calcium channel antagonist, nimodipine. Acta Crystallogr Sect C. 1989;C45:1748–1751.CrossRefGoogle Scholar
  15. 15.
    Urbanetz NA, Lippold BH. Solid dispersions of nimodipine and polyethylene glycol 2000: dissolution properties and physico-chemical characterization. Eur J Pharm Biopharm. 2005;59:107–118.PubMedCrossRefGoogle Scholar
  16. 16.
    Urbanetz NA. Stabllization of solid dispersions of nimodipine and polyethylene glycol. 2000. Eur J Pharm Sci. 2006;28:67–76.PubMedCrossRefGoogle Scholar
  17. 17.
    Papageorgiou GZ, Bikiaris D, Karavas E, et al. Effect of physical state and particle size distribution on dissolution enhancement of nimodipine/PEG solid dispersions prepared by melt mixing and solvent evaporation. AAPS J [serial online]. 2006;8:E623-E631.CrossRefGoogle Scholar
  18. 18.
    Hörter D, Dressman JB. Inffuence of physicochemical properties on dissolution of drugs in the gastrointestinal tract. Adv Drug Deliv Rev. 2001;46:75–87.PubMedCrossRefGoogle Scholar
  19. 19.
    Leuner, C, Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm. 2000;50:47–60.PubMedCrossRefGoogle Scholar
  20. 20.
    Craig DQM. The mechanisms of drug release from solid dispersions in water-soluble polymers. Int J Pharm. 2002231:131–144.PubMedCrossRefGoogle Scholar
  21. 21.
    Ford JL. The current status of solid dispersions. Pharm Acta Helv. 1986;61:69–88.PubMedGoogle Scholar
  22. 22.
    Breitenbach J, Schrof W, Neumann J. Confocal Raman-spectroscopy: analytical approach to solid dispersions and mapping of drugs. Pharm Res. 1999;16:1109–1113.PubMedCrossRefGoogle Scholar
  23. 23.
    Bikiaris D, Papageorgiou GZ, Stergion A, et al. Physicochemical studies on solid dispersions of poorly water-soluble drugs: evaluation of capabilities and limitations of thermal analysis techniques. Thermochim Acta. 2005;439:58–67.CrossRefGoogle Scholar
  24. 24.
    Lin-Vien D, Colthup NB, Fatelay WG, Grasselli JG. The Handbook of Infrared and Raman Characteristic Frequencies of Organic Molecules. London, UK: Academic Press; 1991.Google Scholar
  25. 25.
    Karavas E, Georgarakis E, Bikiaris D. Felodipine nanodispersions as active core for predictable pulsatile chronotherapeutics using PVP/HPMC blends as coating layer. Int J Pharm. 2006;313:189–197.PubMedCrossRefGoogle Scholar
  26. 26.
    Kanaze FI, Kokkalu E, Niopas I, Georgarakis E, Stergiou A, Bikiaris D. Dissolution enhancement of flavonoids by solid dispersion in PVP and PEG matrices: a comparative study. J Appl Polym Sci. 2006;102:460–471.CrossRefGoogle Scholar
  27. 27.
    Karavas E, Georgarakis E, Bikiaris D. Application of PVP/HPMC miscible blends with enhanced mucoadhesive properties for adjusting drug release in predictable pulsatile chronotherapeutics. Eur J Pharm Biopharm. 2006;64:115–116.PubMedCrossRefGoogle Scholar
  28. 28.
    Al Zoubi N, Koundourellis JE, Malamataris S. FT-IR and Raman spectroscopic methods for identification and quantitation of orthorhombic and monoclinic paracetamol in powder mixes. J Pharm Biomed Anal. 2002;29:459–467.CrossRefGoogle Scholar
  29. 29.
    El Hagrasy AS, Chang SY, Desai D, Kiang S. Raman spectroscopy for the determination of coating uniformity of tablets: assessment of product quality and coating pan mixing efficiency during scale-up. J Pharm Innov. 2006;Sept/Oct:37–42.CrossRefGoogle Scholar
  30. 30.
    Griesser UJ, Auer ME, Burger A. Micro-thermal analysis, FTIR- and Raman-microscopy of (R,S)-proxyphylline crystal forms. Microchem J. 2000;65:283–292.CrossRefGoogle Scholar
  31. 31.
    Bell SEJ, Beattie JR, McGarvey JJ, Peters KL, Sirimuthu NMS, Speers SJ. Development of sampling methods for Raman analysis of solid dosage forms of therapeutic and illicit drugs. J Raman Spectrosc. 2004;35:409–417.CrossRefGoogle Scholar
  32. 32.
    O’Brien LE, Timmins P, Williams AC, York P. Use of in situ FT-Raman spectroscopy to study the kinetics of the transformation of carbamazepine polymorphs. J Pharm Biomed Anal. 2004;36:335–340.PubMedCrossRefGoogle Scholar
  33. 33.
    Romero-Torres S, Perez-Ramos J, Morris KR, Grant EE. Raman spectroscopy for tablet coating thickness quantification and coating characterization in the presence of strong fluorescent interference. J Pharm Biomed Anal. 2006;41:811–819.PubMedCrossRefGoogle Scholar
  34. 34.
    Krishna CM, Sockalingum GD, Kegelaer G, Rubin S, Kartha VB, Manfait M. Micro-Raman spectroscopy of mixed cancer cell populations. Vib Spectrosc. 2005;38:95–100.CrossRefGoogle Scholar
  35. 35.
    Koenig JL, Angood AC. Raman spectra of poly(ethylene glycols) in solution. J Polym Sci A. 1970;8:1787–1796.CrossRefGoogle Scholar
  36. 36.
    Verheyen S, Blaton N, Kinget R, Van den Mooter G. Mechanism of increased dissolution of diazepam and temazepam from polyethylene glycol 6000 solid dispersions. Int J Pharm. 2002;249:45–58.PubMedCrossRefGoogle Scholar
  37. 37.
    Suzuki H, Sunada H. Some factors influencing the dissolution of solid dispersions with nicotinamide and hydroxypropylmethylcellulose as combined carriers. Chem Pharm Bull (Tokyo). 1998;46:1015–1020.Google Scholar
  38. 38.
    Saers ES, Nystrom C, Alden M. Physicochemical aspects of drug release, XVI: the effect of storage on drug dissolution from solid dispersions and the influence of cooling rate and incorporation of surfactant. Int J Pharm. 1993;90:105–118.CrossRefGoogle Scholar
  39. 39.
    Serajuddin ATM. Solid dispersion of poorly water soluble drugs: early promises, subsequent problems, and recent breakthroughs. J Pharm Sci. 1999;88:1058–1066.PubMedCrossRefGoogle Scholar
  40. 40.
    Hancock BC, Zografi G. Characteristics and significance of the amorphous state in pharmaceutical systems. J Pharm Sci. 1997;86:1–12.PubMedCrossRefGoogle Scholar
  41. 41.
    Junginger HE, Wedler M. Thermal stability of mefrusidepolyvinylpyrrolidone solid dispersions. Pharm Res. 1986;3:41–44.CrossRefGoogle Scholar
  42. 42.
    Taylor LS, Zografi G. The quantitative analysis of crystallinity using FT-Raman spectroscopy. Pharm Res. 1998;15:755–761.PubMedCrossRefGoogle Scholar
  43. 43.
    Chan KLA, Kazarian SG. FTIR spectroscopic imaging of dissolution of a solid dispersion of nifedipine in poly(ethylene glycol). Mol Pharm. 2004;1:331–335.PubMedCrossRefGoogle Scholar

Copyright information

© American Association of Pharmaceutical Scientists 2007

Authors and Affiliations

  • Aristides Docoslis
    • 1
  • Krista L. Huszarik
    • 1
  • George Z. Papageorgiou
    • 2
  • Dimitrios Bikiaris
    • 2
  • Anagnostis Stergiou
    • 3
  • Emmanouel Georgarakis
    • 4
  1. 1.Department of Chemical EngineeringQueen’s University at KingstonCanada
  2. 2.Laboratory of Orgamic Chemical Technology, Chemistry DepartmentAristotle University of ThessalonikiThessalonikiGreece
  3. 3.Applied Physics Laboratory, Department of PhysicsAristotle University of ThessalonikiThessalonikiGreece
  4. 4.Section of Pharmaceutics and Drug Control, Department of PharmacyAristotle University of ThessalonikiThessalonikiGreece

Personalised recommendations